1. Introduction {#S5}
===============

The prevalence rates of loneliness have been reported to be 35% in U.S. adults aged 45 years and above \[[@R1]\], 27.9% in older adults in Jerusalem \[[@R2]\], 31.5% in Australian older adults, and up to 78% in Chinese older adults \[[@R3],[@R4]\]. Researchers have consistently suggested that diminishing loneliness can improve overall health \[[@R5]\]. Loneliness is recognized as a bio-psychosocial determinant of health \[[@R6]\] in older adult populations worldwide. Loneliness is associated with the activation of the hypothalamic-pituitary-adrenocortical (HPA) axis \[[@R7]\], which elicits a physiological response \[[@R8]\] that contributes to the dysregulation of inflammatory \[[@R9]\], neuroendocrine \[[@R10]\], and immune systems \[[@R11]\]. Through this mechanism, loneliness may contribute to poor control of chronic conditions, including hypertension \[[@R12],[@R13]\] and metabolic problems, such as obesity \[[@R14]\]. In addition, loneliness is linked to multiple behavioral health problems, including anxiety \[[@R15]\], depression \[[@R16]\], substance abuse \[[@R1]\], and suicidal tendency \[[@R17]\]. Over half (56%) of adults in the USA with anxiety have reported loneliness \[[@R1]\]. Loneliness contributes to depression \[[@R11],[@R18]\]; hence, diminishing loneliness can help prevent depression \[[@R16]\], thereby decreasing expenses in healthcare systems \[[@R19]\].

At present, healthcare providers do not have access to a recommended clinically effective treatment for loneliness. Interventions for loneliness have ranged from overemphasis on social reintegration \[[@R20]--[@R24]\] to individual cognitive therapies, such as mindfulness \[[@R25]\]. No single intervention has been determined as effective for diminishing loneliness and its negative health outcomes across age groups or populations. One recent meta-analysis of interventions suggested that effectiveness may be enhanced if interventions targeted common thought process errors that occur with loneliness \[[@R26]\], such as automatic thinking \[[@R27]\] or fears and phobias \[[@R28]\]. In response to this body of knowledge, we developed LISTEN, a novel intervention for loneliness. The initial development, feasibility, and acceptability of LISTEN have been published \[[@R29],[@R30]\].

This initial study on LISTEN was conducted in West Virginia, a state located entirely in Appalachia. The Appalachian region is a known area of health disparity \[[@R31]\]. A disproportionate segment of the region's population is rural \[[@R32]\], impoverished, lowly educated, and physically ill, all of which are linked to poor mental health outcomes \[[@R33]\]. Therefore, more adults in Appalachia may be suffering from loneliness \[[@R15]\] or untreated depression \[[@R34]\]. The rural nature of Appalachia coupled with the lack of public transportation may limit social contacts. In spite of the stereotypical view of Appalachians living rurally with close extended family, other forms of social support may be more important than family proximity in predicting mental health outcomes \[[@R35]\]. Particularly for women, emotional support from friends has been reported to enhance affect \[[@R36]\]. Knowing that adults living rurally may experience a chronic condition with a sense of quiet pride \[[@R37]\] makes it even more important that healthcare providers proactively assess and address problems such as loneliness and depression.

Findings from preliminary qualitative studies on lonely older women living in Appalachia encouraged the development of LISTEN \[[@R29]\]. Lonely older women suffering from chronic illness and living in Appalachia reported that their experience of loneliness is related to negative emotions including fear, anger, and worry. They reported that loneliness can lead to loss of function or independence \[[@R38]\]. Conversely, these women reported positive emotions such as joy when the feeling of loneliness is absent. Participants of the qualitative studies on loneliness in Appalachia reported that staying busy and going out were important to the management of loneliness \[[@R38]\]. This paper presents the effectiveness of LISTEN, an intervention designed to target impaired cognitive processes associated with loneliness, on the psychosocial and physiological measures in a sample of lonely, chronically ill adults living in the communities of Appalachia.

1.1. Theoretical framework for study {#S6}
------------------------------------

A psychoneuroimmunology (PNI) paradigm serves as a theoretical framework for the study design \[[@R39]\]. This paradigm enhances understanding about how the experience of a psychosocial stressor may lead to other physical or behavioral health problems through the physiological response to the stressor. The framework specifically considers how the perception of stress in the presence of existing coping can lead to neuroimmunological responses that affect functional ability, quality of life, and illness progression over time. [Fig. 1](#F1){ref-type="fig"} illustrates the study variables in the model of the PNI paradigm. For the purposes of this study, the research team posited that by diminishing loneliness, participants would experience a diminished physiological response to the stressor of loneliness and then achieve improved health.

2. Study design, setting, subjects, and methods {#S7}
===============================================

2.1. Design, aims, and ethical considerations {#S8}
---------------------------------------------

The study design was a prospective, longitudinal, randomized controlled trial with two groups: LISTEN intervention group and attention control group. The two following *aims* were accomplished by studying a sample of lonely, rural, and chronically ill adults: (1) to evaluate the relative effectiveness of LISTEN for decreasing loneliness and neuroimmunological stress response; and (2) to evaluate the relative effectiveness of LISTEN in improving psychosocial functioning, quality of life, and physical health. The two aims presented two corresponding research questions, as follows. 1) What are the differences between the LISTEN group and the attention control group in morning rise in salivary cortisol, DHEA levels, interleukin (IL)-6, and IL-2? 2) What are the differences between the LISTEN group and the attention control group in terms of depression, loneliness, social support, functional ability, quality of life, glucose, blood pressure, and body mass index (BMI)? Before the study commenced, a letter of approval was obtained from the West Virginia University Institutional Review Board.

2.2. Setting {#S9}
------------

The setting for enrollment in the study was the Clark Sleeth Family Medicine Center, which is a primary care center located in the Health Sciences Center of West Virginia University in North Central West Virginia. Approximately 5600 geriatric outpatients are in this clinic annually. The setting for the delivery of the LISTEN and attention control group sessions was a private room in the Health Sciences Center. This room is accessible to persons with disabilities and can facilitate audio and video recording.

2.3. Subjects {#S10}
-------------

The study established a sampling goal of 30 participants, and the enrollment closed when 27 older adults completed the study. This limitation was necessary because the study required three to five participants to hold concurrent group sessions. Therefore, the subjects for the study were 27 older adults (24 females) with mean age of 75 years old \[(SD 7.50), age range: 65--89 years old\]. The majority of participants lived alone (70.4%), and the remainder lived with either a spouse or daughter. [Table 1](#T1){ref-type="table"} presents the baseline sociodemographic characteristics (pre-intervention Co-Factors in the PNI model) for both groups. To participate in the study, potential participants should meet the following inclusion criteria. 1) All patients should be 65 years of age or older. 2) They must have a minimum loneliness score of 40 on the revised 20-item UCLA Loneliness scale \[[@R40]\]. 3) Participants should be living in the community. 4) They have been diagnosed with at least one chronic illness. 5) Each participant must have voluntarily signed an informed consent form prior to enrollment. Participants were excluded on the basis of the following criteria. 1) Potential participants who had lost their spouse within the last 2 years were excluded to control for grief reaction. 2) Those who had cognitive impairment with scores less than 23 on the Folstein mini-mental status exam did not participate. 3) Those with institutional living were excluded. 4) Those with significant psychiatric or developmental problems that prevented their ability to independently answer survey questions were also excluded.

2.4. Study procedures {#S11}
---------------------

Participants were recruited through advertisement in a family primary care center, which was university based and serves as a multi-county area of rural and small urban communities. The study team also placed advertisements in local and regional newspapers. Potential participants contacted the clinic via phone to volunteer. Prior to enrollment, all potential participants completed a screening to assess for meeting the basic inclusion and exclusion criteria. Participants were then scheduled for the initial enrollment meeting, in which they were first given the opportunity to read all informed consent forms and ask questions. After the participants signed consent to participate, baseline enrollment data were collected, and the participants were randomized into either LISTEN group or educational attention control group. Both groups (three to five participants at a time) met weekly for a total of five times (2 h each time). Reminder letters and phone calls were used for the weekly group sessions. After completing the fifth session, the participants answered survey questions by phone at 1 and 6 weeks after the last group session and attended a face-to-face meeting at 12 weeks post-intervention for final data collection.

2.5. Study comparators {#S12}
----------------------

### 2.5.1. LISTEN: the intervention {#S13}

LISTEN was developed using the Medical Research Council framework for complex intervention development \[[@R41]\]. The development process of LISTEN, including information about the underlying theoretical frameworks, has been previously published \[[@R29]\] along with the initial feasibility and acceptability evaluation data \[[@R30]\]. The psychophysiological links between loneliness and chronic illness made it logical to propose an intervention that targeted this stress mechanism by encouraging rethinking the experience of loneliness to enhancing meaning and facilitate moving forward. LISTEN is delivered sequentially and weekly, in five 2 h sessions. The content of the sessions was derived from the health and social science literature on loneliness, and the sessions are designed to be sequential, focusing first on belonging, then relationships, role in community, loneliness as a health challenge, and meaning of loneliness. Participants begin each session with writing; during weeks 1--4, the participants complete unique homework assignments relevant to the content for the upcoming week.

### 2.5.2. Attention control group {#S14}

The attention control group met weekly for 2 h time periods each week for a total of 5 weeks. This group received educational information about aging, including contents on Common Physical Changes with Aging, Eating for Health, Aging and Health, Stroke Prevention, and Preventive Care. The attention control group educational sessions were scripted; hence, the content was the same for each small group.

2.6. Fidelity to the intervention {#S15}
---------------------------------

The LISTEN and attention control groups met on the same days, at the same time, and in similar location and room settings; both groups were given the same break with the same refreshments. The LISTEN and attention control groups had separate trained interventionists to prevent contamination of the intervention. Prior to the intervention study, all team members were trained to understand the study protocol, which was reviewed prior to enrollment of each cohort of patients. All intervention and control group sessions were audio and video recorded to assess for fidelity to LISTEN and to assess for potential contamination in the attention control group. Recordings were reviewed by the study team after each session to monitor the fidelity to LISTEN.

2.7. Instruments and measures {#S16}
-----------------------------

### 2.7.1. Neuroimmunological stress {#S17}

Salivary cortisol, DHEA, IL-6, and IL-2 levels were measured at enrollment and at 12 weeks after the final intervention session as indicators of physiological stress response, inflammation, and immunity. The Adrenocortex Stress Profile Kit was used as a measure of salivary cortisol. Saliva was collected from the participants at four different time points in a 24 h period, and the study team then transported the saliva samples to the University Medical Laboratories, where the samples were sent out for analysis to Genova Diagnostics \[[@R42]\]. The Adrenocortex Stress Profile evaluates cortisol and DHEA levels, both of which are linked to anti-inflammatory response and stress resistance. IL-6 and IL-2 were determined from the blood samples processed at the University Medical Laboratories \[[@R43]\].

### 2.7.2. Psychosocial functioning {#S18}

Depression was measured using the five-item Geriatric Depression Scale (GDS) \[[@R44]\]. The current scale was reported as comparable to prior versions of GDS in both reliability and validity in populations of older adults. Loneliness was measured using the revised UCLA Loneliness Scale \[[@R40]\]. The scale consists of 20 items with several items reverse scored, and the possible total scores range from 20 to 80. This scale has been reported as reliable and valid in varied populations \[[@R45]\]. Loneliness was assessed at enrollment and at 1, 6, and 12 weeks after the last intervention session. Social support was measured using the MOS Social Support Scale. This scale includes subscales of tangible support, emotional support, and affective support and has been widely used to assess social support in varied populations \[[@R46]\]. Functional ability was assessed using the Katz ADL and IADL instruments \[[@R47]\]. The Katz Activities of Daily Living instruments have been used widely in populations of older adults to assess basic and instrumental functional ability. All measures of psychosocial functioning were collected at enrollment and at 12 weeks after the last intervention session.

### 2.7.3. Quality of life {#S19}

The quality of life was measured using a visual analog scale ranging from 0 to 10. This scale has been reported as highly correlating with other measures of quality of life \[[@R48]\]. The quality of life was assessed at enrollment and at 1, 6, and 12 weeks after the last intervention session.

### 2.7.4. Physical health measures {#S20}

Blood pressure was measured by a trained registered nurse using an appropriately calibrated sphygmomanometer. Fasting glucose was measured after the participants fasted for at least 8 h. The fasting glucose level was measured by a trained registered nurse using an appropriately calibrated glucometer. BMI was calculated using the measures of height and weight taken in the family medicine center by using a calibrated scale and height measure. Physical measures were collected at enrollment and at 12 weeks after the last intervention session.

3. Statistical analyses {#S21}
=======================

Data were analyzed using Statistical Package for the Social Sciences 23.0. Methods for analysis included a comprehensive descriptive analysis of all study variables, followed by bivariate analysis for significant relationships among the study variables. Mean comparisons were conducted using a repeated-measures analysis of variance for the main study outcome variables while controlling for baseline depressive symptoms. The level of statistical significance was set at *p* \< 0.05. Loneliness and quality of life were the only two variables collected at four time points. For these two variables, Mauchly's test was performed to assess the effect size within subjects.

4. Results {#S22}
==========

The LISTEN and attention control groups did not differ significantly on any of the baseline demographic characteristics ([Table 1](#T1){ref-type="table"}). [Table 2](#T2){ref-type="table"} provides the mean comparisons between baseline measures and those at 12 weeks after the last intervention session for outcome variables measured alone at these time points.

4.1. Neuroimmunological stress {#S23}
------------------------------

Morning rise in salivary cortisol changed over the course of the study. Both LISTEN and control group means decreased between enrollment and 12 weeks post-intervention. DHEA, IL-6, and IL-2 were not significant, but both the LISTEN and control groups decreased in morning rise in cortisol and DHEA over the course of the study. In addition, mean levels of IL-6 increased for both groups. The groups were not equal at baseline on IL-6. This finding may be attributed to the different experiences of chronic illnesses, including rheumatoid arthritis, and this result may have skewed the Il-6 data. However, even when controlling for the chronic illness diagnoses, the IL-6 values were not significantly different from baseline to 12 weeks post-intervention. The mean levels of IL-2 decreased for the LISTEN group and increased for the attention control group, but the difference was not significant.

4.2. Psychosocial functioning and quality of life {#S24}
-------------------------------------------------

Twelve weeks after the last intervention session, the LISTEN group presented reduced depressive symptoms, and this finding was clinically relevant but not statistically significant. At completion of the study, the LISTEN group demonstrated significantly less loneliness (*p* = 0.018) than that of the attention control group. Loneliness and quality of life were assessed at four time points, and the mean comparisons for these variables are presented in [Table 3](#T3){ref-type="table"}. When loneliness was compared at all four time points for within-subjects effect and while controlling for baseline depressive symptoms, Mauchly's W was 0.725 (*p* = 0.198). Assuming sphericity, the Epsilon^b^ Greenhouse--Geisser value was 0.859, and the four means were not equal \[F (3, 72) = 3.060, *p* = 0.034\]. [Fig. 2](#F2){ref-type="fig"} illustrates the mean loneliness scores at each time point; as shown in the figure, the loneliness in the LISTEN group continued to decline, whereas the attention control group achieved mean loneliness scores that trended upward between 6 and 12 weeks after the last session.

The mean quality-of-life scores are also presented in [Table 3](#T3){ref-type="table"}. As shown in the table, the quality of life increased slightly for the LISTEN group and decreased slightly for the attention control group, but the changes were not significant. The total social support scores changed with mean scores for the LISTEN group increasing significantly (*p* = 0.05). The subscale with the greatest change was the tangible support subscale, in which the control group reported less support, whereas the LISTEN group reported more support (*p* = 0.01). The LISTEN group reported maintenance of basic functional ability, whereas the attention control group reported a slight decline in function.

4.3. Physical health measures {#S25}
-----------------------------

The LISTEN group demonstrated clinically relevant changes in fasting glucose, but these changes were not statistically significant. The mean fasting glucose levels increased in both groups at baseline. The LISTEN group achieved \<1 mg/dl change in mean fasting glucose, whereas the control group, who received lectures on healthy diet, yielded a mean increase of 10.1 mg/dl in mean fasting glucose. The changes in systolic blood pressure were statistically significant (*p* = 0.018) with mean systolic blood pressures in the LISTEN group dropping below 130, which is a clinically relevant finding in an older adult sample. The mean diastolic blood pressure and BMI did not differ significantly between the groups after intervention.

5. Discussion {#S26}
=============

This study employed a randomized controlled trial design to identify LISTEN as a potential intervention for diminishing loneliness and the poor health outcomes associated with loneliness in chronically ill, lonely, older adults. Prior reviews of interventions and one meta-analysis of interventions \[[@R26]\] suggested that the most successful intervention for loneliness would be one that specifically targets the cognitive mis-perceptions or thinking errors that occur during loneliness.

This study is the first to employ LISTEN as a potential method to reduce feelings of loneliness. LISTEN is the first group intervention designed to bring lonely people together to offer their narrative of loneliness in a therapeutic environment and in a sequenced way, aiming to facilitate cognitive restructuring. The structure of this intervention facilitates a change in cognitive perspective; hence, one can view loneliness as an experience that can be challenged with individualized actions.

The findings of this study will provide additional information about the relationship between loneliness and depressive symptoms. Primarily, participants of the LISTEN group reported diminished depressive symptoms; this result is significant, given the links between depression and negative health outcomes, which recently included sensory impairments and suicide \[[@R49],[@R50]\]. The findings emphasize that untreated loneliness can lead to an increase in depressive symptoms in a relatively short period of time. Previous literature reported that loneliness and depression are separate unique constructs \[[@R51]\]; loneliness is predictive of depression \[[@R16]\], and this relationship is not reciprocal. Our findings indicating that untreated lonely persons may report increased depressive symptoms over a period of only 4 months emphasize the need for proactive assessment and treatment of loneliness. Considering that depression is negatively associated with poor chronic illness outcomes \[[@R15]\], depression should be prevented if possible. Research has posited that treating loneliness prior to the development of depressive symptoms can significantly reduce such symptoms, thereby greatly saving expenses on the healthcare system \[[@R52]\].

An extensive literature on loneliness and social support has detailed how people who perceive social support to be low may experience loneliness. Particularly in older adult populations worldwide, lonely older adults have reported social isolation \[[@R53]\], lack of meaningful connection \[[@R54]\], or diminished social networks \[[@R55]\]. Our findings indicating that participants of LISTEN perceived overall enhanced social support were unexpected because participating in LISTEN did not provide any enhancement of tangible support. The structure of LISTEN may have contributed to this change because participants of LISTEN reported that they were beginning to take actions against loneliness by seeking tangible means of support, joining exercise courses, and joining community organizations. These actions occurred after gaining the opportunity to cognitively process their experience of loneliness.

LISTEN integrates the key concepts from narrative therapy and cognitive behavioral therapy to offer the participants the opportunity to share a narrative of their personal experience of loneliness. Narrative therapy has been used to diminish depressive symptoms, and recent studies have concluded that both narrative therapy and cognitive behavioral therapy can result in diminished depressive symptoms \[[@R56]\]. Being able to share one's experience of loneliness and live the vicarious experience of another who is lonely may have changed the perception of social support \[[@R57]\] for participants of the LISTEN group.

Two national data analyses have identified loneliness as a predictive factor of functional decline and mortality in older adult samples \[[@R58],[@R59]\]. The current literature links loneliness to the decline of both physical and cognitive functions \[[@R60]\]. Considering that the LISTEN group maintained physical functional ability, the diminishing loneliness may result in behavioral changes that can facilitate maintenance of function. Given that the untreated group diminished slightly in both basic and instrumental activities of daily living, the importance of taking on loneliness as a complex health phenomenon is highlighted. Longitudinal studies on LISTEN are needed to further determine whether diminishing loneliness in chronically ill, lonely, older adults can result in any regained functional ability. Lonely older adults may lose function because of their self-isolating behavior or lack of activity. Therefore, with the right support or intervention, intrinsic motivation can be altered and may lead to increased activity.

The findings related to salivary cortisol, DHEA, IL-6, and IL-2 are exploratory and have created more questions. The diminished rise in salivary cortisol in the control group may indicate underlying chronic stress response and flattening of the cortisol rhythm \[[@R8]\]. Given that the present study had the inclusion criterion of a minimum UCLA loneliness score of 40, all the study participants were at least moderately lonely and were likely to demonstrate a slightly flattened cortisol rhythm at study enrollment. Although the loneliness of the LISTEN participants decreased significantly, the mean scores at 12 weeks were still not indicative of the overall absence of loneliness. In addition, the participants presented multiple chronic conditions, including rheumatoid arthritis, which may have skewed the IL6 results \[[@R61]\]. Recent studies indicate that lonely older adults showed increased cytokine production compared with non-lonely persons; this finding suggests a proinflammatory response \[[@R62]\].

The findings related to physical health measures are consistent with the literature indicating that loneliness is linked to hypertension \[[@R63]\] through the physiological stress response \[[@R9]\]. Changes in systolic blood pressure were clinically significant because the mean systolic blood pressure of the LISTEN group decreased within the guidelines for management of hypertension for older adults \[[@R64]\]. This finding is very important because patients seen clinically and are above this goal are frequently prescribed with higher doses of new antihypertensive medication, which can lead to other adverse reactions. Previous studies indicated that loneliness can increase blood pressure over long periods of time \[[@R65]\], and this effect is very problematic given the relationship between high blood pressure, cardiovascular illness, and stroke. Thus, diminishing the physiological stress response to loneliness can prevent hypertension. One of the potential downstream effects is the prevention of stroke or secondary stroke. Our preliminary studies on loneliness of ischemic stroke survivors in Appalachia indicate that loneliness is a prevalent problem for stroke survivors, and this feeling is linked to multiple domains in this population \[[@R66]\].

5.1. Limitations {#S27}
----------------

The main limitation of this study is the relatively small homogeneous sample. The majority of female sample limits true generalizability of the findings to older men in Appalachia. The participants were all community dwelling; hence, the findings cannot be generalized to older adults living in long-term care or other assisted living settings. Moreover, the participants were not assessed for being native to Appalachia. Given that Appalachian women identify strongly with their kin, this factor is also a limitation. Assessing for birthplace in future studies will be important; consequently, logical inferences can be made regarding loneliness and Appalachian culture.

5.2. Planning for future research {#S28}
---------------------------------

Future steps will be multifaceted and will comprehensively evaluate the potential use of LISTEN as a therapeutic strategy for loneliness in varied populations. The study team is currently evaluating the feasibility and acceptability of LISTEN as a therapy for loneliness in survivors of ischemic stroke (funded by WVCTSI NIGM, U54GM104942). Additional studies on the significance of the changes in IL-6 and IL-2 are needed to further determine how the treatment of loneliness can affect inflammatory or immune changes that may in turn influence chronic conditions. The planned subsequent steps include seeking funding to conduct large-scale longitudinal trials of LISTEN to appropriately assess the long-term health and health system benefits of diminishing loneliness. Future trials are being designed to report on the resources needed to deliver LISTEN, as well as the potential scalability, replicability, and costs of such delivery. In summary, LISTEN can effectively diminish loneliness and reduce systolic blood pressure, with increased self-reported social support compared with the attention control group. The importance of sharing experiences of loneliness and gaining the opportunity to find out how others are coping with loneliness was described by the participants as the most significant part of their participation in LISTEN. Study participants noted that being open to listening to how others coped with loneliness led to the adoption of new behavior after completing the study.

![Study variables illustrated in the psychoneuroimmunology paradigm.](nihms877805f1){#F1}

![Changes in mean loneliness scores from baseline to 12 weeks post intervention.](nihms877805f2){#F2}

###### 

Baseline characteristics of randomized participants.

  Variable                                        LISTEN group (*N* = 15)   AC group (*N* = 12)   Difference statistic
  ----------------------------------------------- ------------------------- --------------------- ---------------------------
  Age \[mean years (SD)\]                         74.93 (7.39)              75.21 (7.97)          *t* = *0.9, p* = *0.93*
  Gender                                                                                          χ2 = 2.70, *p* = 0.10
   Male                                           3                         0                     
   Female                                         12                        12                    
  Marital status                                                                                  χ2 = 0.49, *p* = 0.78
   Married, spouse in home                        4                         4                     
   Separated, divorced, never married             7                         4                     
   Widowed                                        4                         4                     
  Highest education completed                                                                     χ2 = 1.02, *p* = 0.79
   High school or less                            3                         4                     
   Some college                                   3                         2                     
   Undergraduate degree                           6                         3                     
   Graduate degree                                3                         3                     
  Household Income (\$/year)                                                                      χ2 = 2.37, *p* = 0.31
   Less than \$20,000                             4                         6                     
   \$20,001 to \$40,000                           8                         3                     
   Over \$40,000                                  3                         3                     
  Number of people living in home \[mean (SD)\]   1.36 (0.75)               1.50 (0.80)           *t* = *0.47, p* = *0.64*
  Employment status                                                                               χ2 = 1.49, *p* = 0.48
   Retired and not working                        12                        8                     
   Working part-time                              3                         3                     
   Working full-time                              0                         1                     
  Total Katz basic ADLs \[mean (SD)\]             6.5 (0.9)                 6.4 (1.2)             *t* = −*0.13, p* = *0.90*
  Total Katz instrumental ADLs \[mean (SD)\]      13.2 (3.2)                13.2 (3.2)            *t* = −*0.01, p* = *0.99*
  Total chronic illnesses \[mean (SD)\]           2.9 (0.38)                2.6 (1.6)             *t* = −*0.47, p* = *0.64*
  Loneliness score \[mean (SD)\]                  47.0 (6.5)                51.8 (9.5)            *t* = *1.53, p* = *0.14*

*Note.* AC = attention control, SD = standard deviation, total values may not be exactly 100% because of estimation.

*Note.* Chi-Square test for gender was performed only for a 2 × 2 table because no males were randomized to the control group.

The t and chi-square symbols were italicized to indicate the statistical test and the N was italicized as it is an abbreviation for sample size of each group.

###### 

Mean comparisons for outcome variables measured at enrollment and 12 weeks post-intervention.

  Outcome                                Group    Baseline   12 Weeks post   F        p               
  -------------------------------------- -------- ---------- --------------- -------- ------- ------- ----------------------------------------
  Morning rise in salivary cortisol      LISTEN   0.58       0.45            0.46     0.68    3.65    [\*](#TFN5){ref-type="table-fn"}0.07
  Control                                0.55     0.34       0.34            0.23                     
  DHEA                                   LISTEN   76.48      51.22           39.30    42.05   0.76    0.39
  Control                                82.82    46.49      61.73           64.52                    
  IL-6                                   LISTEN   6.25       12.19           9.62     17.91   0.38    0.54
  Control                                0.99     7.24       7.66            16.6                     
  IL-2                                   LISTEN   2.25       0.59            2.06     0.39    0.277   0.60
  Control                                2.34     0.43       2.64            0.69                     
  Depression (GDS)                       LISTEN   1.96       1.34            .852     1.06    3.779   0.13
  Control                                1.79     1.42       1.81            1.79                     
  MOS total social support               LISTEN   59.13      15.9            64.98    12.49   3.99    [\*](#TFN5){ref-type="table-fn"}0.05
  Control                                56.36    19.07      52.36           16.42                    
  Emotional support subscale             LISTEN   22.47      7.29            24.57    7.12    2.31    0.14
  Control                                20.75    8.66       22.42           5.93                     
  Tangible support subscale              LISTEN   12.33      5.31            14.38    4.00    7.01    [\*\*](#TFN6){ref-type="table-fn"}0.01
  Control                                12.82    5.05       10.36           5.27                     
  Affectionate support subscale          LISTEN   10.60      3.31            11.93    2.22    1.21    0.28
  Control                                9.67     4.07       9.75            4.63                     
  Positive social interaction subscale   LISTEN   10.47      3.33            10.58    2.36    0.31    0.58
  Control                                9.17     4.30       8.67            3.05                     
  Basic ADL                              LISTEN   6.47       0.91            6.49     0.91    0.92    0.35
  Control                                6.42     1.16       6.08            0.29                     
  Instrumental ADL                       LISTEN   13.20      3.19            12.73    2.31    2.92    0.10
  Control                                13.45    3.29       12.36           3.35                     
  Fasting glucose                        LISTEN   111.8      48.77           112.08   19.24   0.43    0.51
  Control                                108.7    36.24      118.80          60.40                    
  Systolic blood pressure                LISTEN   137.63     14.41           126.93   13.62   6.43    [\*](#TFN5){ref-type="table-fn"}0.02
  Control                                132.67   20.84      130.00          18.33                    
  Diastolic blood pressure               LISTEN   77.98      8.18            75.00    9.03    1.92    0.18
  Control                                77.33    11.95      74.58           9.13                     
  Body mass index                        LISTEN   29.94      7.93            29.52    7.97    2.61    0.12
  Control                                30.67    5.91       29.53           7.97                     

*Note.* Variables are presented in order of presentation in the PNI model ([Fig. 1](#F1){ref-type="fig"}).

= p ≤ .05,

= p ≤ .01. GDS is the 5-item Geriatric Depression Scale.

###### 

Mean comparisons for loneliness and quality of life.

  Outcome                 Group    Baseline   1 Week post   6 Weeks post   12 Weeks post   F       p                              
  ----------------------- -------- ---------- ------------- -------------- --------------- ------- ------- ------- ------ ------- --------------------------------------
  Loneliness (R--UCLA)    LISTEN   46.00      5.33          43.57          5.89            43.79   7.18    41.19   5.83   4.142   [\*](#TFN8){ref-type="table-fn"}0.02
  Control                 51.79    9.55       48.08         10.47          45.42           11.43   47.79   8.39                   
  Quality of life (VAS)   LISTEN   7.07       1.94          7.33           1.59            7.26    1.98    7.90    1.49   1.168   0.13
  Control                 7.41     1.91       6.33          2.10           6.79            3.08    6.96    1.98                   

*Note.* R-UCLA is the revised 20-item UCLA Loneliness Scale (scores range from 20 to 80). VAS is the Visual Analog Scale for Quality of Life (scores range from 0 to 10).

= *p* \< 0.05.
